Rockwell Medical Technologies (RMTI) Reports In-Line Q2 Revenue
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.99 --0%
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.9%
Financial Fact:
Selling, General and Administrative: 5.07M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.24), may not compare to the analyst estimate of ($0.13). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.9 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Hyperion DeFi raises FY26 guidance, launches $20M buyback
- ASP Isotopes holds first capital markets day, targets $300M EBITDA by 2031
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
